Intravenous Administration of Human Amniotic Mesenchymal Stem Cells in the Subacute Phase of Cerebral Infarction in a Mouse Model Ameliorates Neurological Disturbance by Suppressing Blood Brain Barrier Disruption and Apoptosis via Immunomodulation - Yoshida, Yasunori; Takagi, Toshinori; Kuramoto, Yoji; Tatebayashi, Kotaro; Shirakawa, Manabu; Yamahara, Kenichi; Doe, Nobutaka; Yoshimura, Shinichi (Cell transplantation, 2021)
Keywords: Apoptosis; Blood-brain barrier; CD11b antigen; Cell therapy; Cerebral blood flow; Cerebral infarction; Gelatinase A; Gelatinase B; Immunofluorescence; Immunogenicity; Immunomodulation; Inflammation; Intravenous administration; Ischemia; Mesenchymal stem cells; Neurological diseases; Nitric-oxide synthase; Original; Phenotypes; Stem cell transplantation; Stem cells; Tumor necrosis factor-α; Tumorigenicity; MCAO; mouse; human amniotic mesenchymal stem cells; cell therapy; ischemic stroke; amnion